Meeting
2021 ASCO Annual Meeting
Phase I trial of fourth-generation chimeric antigen receptor T-cells targeting glypican-3 for advanced hepatocellular carcinoma.
Authors
Weijia Fang
Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
Weijia Fang , Qihan Fu , Qingwei Zhao , Yi Zheng , Lulu Liu , Zonghai Li , Xiaomeng Dai , Huamao Wang , Xudong Zhu , Peng Zhao , Meihua Lin , Hangyu Zhang , Jun Xiao , Jian Liu , Zhou Tong , Zhen Wang , Tingbo Liang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Hepatobiliary Cancer
Clinical Trial Registration Number
NCT03980288
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 4088)
DOI
10.1200/JCO.2021.39.15_suppl.4088
Abstract #
4088
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase I study of GPC3 targeted CAR-T cell therapy in advanced GPC3-expressing hepatocellular carcinoma (HCC).
First Author: Changqing Xie
Poster
2013 Gastrointestinal Cancers Symposium
A phase I study of GC33 in Japanese patients with advanced hepatocellular carcinoma (HCC).
First Author: Takuji Okusaka
Poster
2023 ASCO Annual Meeting
Final results from phase I study of PSCA-targeted chimeric antigen receptor (CAR) T cells in patients with metastatic castration resistant prostate cancer (mCRPC).
First Author: Tanya B. Dorff
First Author: Tianhang Luo